F&O Strategy: Long Straddle on Fin Nifty
The long-term outlook for Nifty Financial Services (Fin Nifty) (23,641.75) will be positive as long as it stays above 18,890.
Continue reading
Category: Stocks
Equity markets to take cue from global trends this week: Analysts
Equity markets will take cues from global trends and trading activity of foreign investors, while in the latter part of
Continue reading
Mcap: 8 of top-10 most-valued firms jumps ₹1.83 lakh cr; TCS, Infosys biggest gainers
Eight of the top-10 most valued firms together added ₹1,83,290.36 crore in market valuation last week, with IT majors Tata
Continue reading
Short Take: Mphasis F&O Contracts Adjustment
Mphasis (₹2,628.9) announced an interim dividend of ₹55 per equity share of face value ₹10 for the financial year 2023-24.
Continue reading
F&O Query: Should you Buy or Sell Stock Derivatives?
Can I buy the July expiry TCS 4100-strike call option? Anil Kewalramani Tata Consultancy Services (₹4,011.8): The stock of TCS
Continue reading
Indian equities attract nearly $1 billion FPI Inflows in early July 2024
Ahead of Modi 3.0 Government’s full budget on July 23, Foreign Portfolio Investors (FPI) continued to show strong buying interest
Continue reading
Broker’s call: Indigo Paints (Buy)
Target: ₹1,594 CMP: ₹1,400.10 Indigo Paints Ltd (IPL) ranks as India’s fifth-largest decorative paint manufacturer by revenue in FY24. The
Continue reading
Will cap on SME listing gains check exuberance?
To moderate the overwhelming euphoria in the SME market, both the regulator and exchanges have decided to implement concrete measures.
Continue reading
India at cusp of major economic transformation: Marcellus
Marcellus Investment Managers, one of the leading portfolio management service providers, believes smartphones, active pharmaceutical ingredients (APIs) and medical devices
Continue reading
Nephro Care makes 100% gain at NSE-SME listing
Shares of Nephro Care India on Friday made strong listing by gaining 90 per cent at ₹171 against the IPO
Continue reading